Cargando…

Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?

Neurodegenerative disorders such as Parkinson’s (PD) and Huntington’s disease (HD) are characterized by a selective detrimental impact on neurons in a specific brain area. Currently, these diseases have no cures, although some promising trials of therapies that may be able to slow the loss of brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salado-Manzano, Cristina, Perpiña, Unai, Straccia, Marco, Molina-Ruiz, Francisco J., Cozzi, Emanuele, Rosser, Anne E., Canals, Josep M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433375/ https://www.ncbi.nlm.nih.gov/pubmed/32848630 http://dx.doi.org/10.3389/fncel.2020.00250

Ejemplares similares

Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder
por: Rosser, Anne E., et al.
Publicado: (2022)

Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
por: Valente, Tony, et al.
Publicado: (2017)

Expanding Arsenal against Neurodegenerative Diseases Using Quercetin Based Nanoformulations: Breakthroughs and Bottlenecks
por: Vishwas, Sukriti, et al.
Publicado: (2023)

Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
por: Kim, Anya, et al.
Publicado: (2020)

Lack of Helios During Neural Development Induces Adult Schizophrenia-Like Behaviors Associated With Aberrant Levels of the TRIF-Recruiter Protein WDFY1
por: Sancho-Balsells, Anna, et al.
Publicado: (2020)

Kv7 channels are upregulated during striatal neuron development and promote maturation of human iPSC-derived neurons
por: Telezhkin, Vsevolod, et al.
Publicado: (2018)

Expansion and contraction of resource allocation in sensory bottlenecks
por: Edmondson, Laura R, et al.
Publicado: (2022)

Bottlenecks to clinical translation of direct brain-computer interfaces
por: Serruya, Mijail D.
Publicado: (2014)

Bottlenecks, Modularity, and the Neural Control of Behavior
por: Nande, Anjalika, et al.
Publicado: (2022)

Quantized response times are a signature of a neuronal bottleneck in decision
por: Perona, Pietro
Publicado: (2014)

Information Bottleneck as Optimisation Method for SSVEP-Based BCI
por: Ingel, Anti, et al.
Publicado: (2021)

The Optic Canal: A Bottleneck for Cerebrospinal Fluid Dynamics in Normal-Tension Glaucoma?
por: Pircher, Achmed, et al.
Publicado: (2017)

Routing Brain Traffic Through the Von Neumann Bottleneck: Parallel Sorting and Refactoring
por: Pronold, Jari, et al.
Publicado: (2022)

Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
por: Peng, Yong, et al.
Publicado: (2023)

Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions
por: Zhu, Xiaolin, et al.
Publicado: (2021)

CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
por: Yang, Weili, et al.
Publicado: (2016)

Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock
por: Martier, Raygene, et al.
Publicado: (2020)

Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies
por: Wu, Erxi, et al.
Publicado: (2023)

Breaking Bottlenecks for the TCR Therapy of Cancer
por: Gaissmaier, Lena, et al.
Publicado: (2020)

Is integration and survival of newborn neurons the bottleneck for effective neural repair by endogenous neural precursor cells?
por: Turnley, Ann M., et al.
Publicado: (2014)

Central as well as Peripheral Attentional Bottlenecks in Dual-Task Performance Activate Lateral Prefrontal Cortices
por: Szameitat, André J., et al.
Publicado: (2016)

Sublinear information bottleneck based two-stage deep learning approach to genealogy layout recognition
por: You, Jianing, et al.
Publicado: (2023)

Implications of glial nitric oxide in neurodegenerative diseases
por: Yuste, Jose Enrique, et al.
Publicado: (2015)

Gliosis and Neurodegenerative Diseases: The Role of PET and MR Imaging
por: Cavaliere, Carlo, et al.
Publicado: (2020)

On the Difference between the Information Bottleneck and the Deep Information Bottleneck
por: Wieczorek, Aleksander, et al.
Publicado: (2020)

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
por: Comella Bolla, Andrea, et al.
Publicado: (2019)

Neuregulins in Neurodegenerative Diseases
por: Ou, Guan-yong, et al.
Publicado: (2021)

Sphingolipids in neurodegenerative diseases
por: Pan, Xueyang, et al.
Publicado: (2023)

Out of the bottleneck
por: Charpak, Georges
Publicado: (2004)

The Business Bottleneck
por: Cote, Michael
Publicado: (2020)

Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders
por: Saniotis, Arthur, et al.
Publicado: (2018)

Perspectives of Circadian-Based Music Therapy for the Pathogenesis and Symptomatic Treatment of Neurodegenerative Disorders
por: Sharma, Arastu, et al.
Publicado: (2022)

Maximizing the Treatment Benefit of tDCS in Neurodegenerative Anomia
por: Roncero, Carlos, et al.
Publicado: (2019)

Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
por: Budini, Mauricio, et al.
Publicado: (2017)

Ubiquitin pathways in neurodegenerative disease
por: Atkin, Graham, et al.
Publicado: (2014)

Zinc homeostasis and neurodegenerative disorders
por: Szewczyk, Bernadeta
Publicado: (2013)

Parkin Regulation and Neurodegenerative Disorders
por: Zhang, Cheng-Wu, et al.
Publicado: (2016)

Amyloidosis in Retinal Neurodegenerative Diseases
por: Masuzzo, Ambra, et al.
Publicado: (2016)

Bile Acids in Neurodegenerative Disorders
por: Ackerman, Hayley D., et al.
Publicado: (2016)

Vergence and Strabismus in Neurodegenerative Disorders
por: Kang, Sarah L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hceo10sccn61oj49fsqnhjc7gs